Challenges in Managing Acute Bleeding in Patients with Hemophilia (Part 2 of 3)

Part 2: Considerations in Controlling Bleeding and Preventing Thrombosis

Faculty:

William E. Dager, Pharm.D., BCPS (AQ-Cardiology)

Pharmacist Specialist

UC Davis Medical Center

Sacramento, California

Mark T. Reding, M.D.

Director, Center for Bleeding and Clotting Disorders

University of Minnesota Medical Center, Fairview

Associate Professor

University of Minnesota Medical School

Minneapolis, Minnesota

C.E. Credits: This activity is not eligible for continuing education credits.

Challenges in Managing Acute Bleeding in Patients with Hemophilia (Part 1 of 3)

Part 3: Monitoring and Dosing Considerations

Faculty:

William E. Dager, Pharm.D., BCPS (AQ-Cardiology)

Pharmacist Specialist

UC Davis Medical Center

Sacramento, California

Surabhi Palkimas, Pharm.D.

Pharmacy Clinical Coordinator, Hematology

University of Virginia Health System

Charlottesville, Virginia

C.E. Credits: This activity is not eligible for continuing education credits.

Emerging Treatment Options for the Reversal of Oral Anticoagulant Therapy - Faculty Roundtable Discussion (Part 1 of 3)

Part 1: Issues Related to Warfarin Reversal

Faculty:

Edith A. Nutescu, Pharm.D., FCCP, Chair and Moderator

Clinical Professor

The University of Illinois at Chicago College of Pharmacy

Director, Antithrombosis Center

The University of Illinois Hospital and Health Sciences System

Chicago, Illinois

William E. Dager, Pharm.D., BCPS (AQ-Cardiology)

Pharmacist Specialist

UC Davis Medical Center

Sacramento, California

James S. Kalus, Pharm.D., BCPS (AQ-Cardiology)

Senior Manager, Patient Care Services

Department of Pharmacy Services

Henry Ford Hospital

C.E. Credits: This activity is not eligible for continuing education credits.

Emerging Treatment Options for the Reversal of Oral Anticoagulant Therapy - Faculty Roundtable Discussion (Part 2 of 4)

Part 2: Usefulness of Coagulation Assays in Patients taking Target-Specific Oral Anticoagulants

Faculty:

Edith A. Nutescu, Pharm.D., FCCP, Chair and Moderator

Clinical Professor

The University of Illinois at Chicago College of Pharmacy

Director, Antithrombosis Center

The University of Illinois Hospital and Health Sciences System

Chicago, Illinois

William E. Dager, Pharm.D., BCPS (AQ-Cardiology)

Pharmacist Specialist

UC Davis Medical Center

Sacramento, California

James S. Kalus, Pharm.D., BCPS (AQ-Cardiology)

Senior Manager, Patient Care Services

Department of Pharmacy Services

Henry Ford Hospital

C.E. Credits: This activity is not eligible for continuing education credits.

Emerging Treatment Options for the Reversal of Oral Anticoagulant Therapy - Faculty Roundtable Discussion (Part 3 of 4)

Part 3: Balancing Bleeding and Thrombosis Risk

Faculty:

Edith A. Nutescu, Pharm.D., FCCP, Chair and Moderator

Clinical Professor

The University of Illinois at Chicago College of Pharmacy

Director, Antithrombosis Center

The University of Illinois Hospital and Health Sciences System

Chicago, Illinois

William E. Dager, Pharm.D., BCPS (AQ-Cardiology)

Pharmacist Specialist

UC Davis Medical Center

Sacramento, California

James S. Kalus, Pharm.D., BCPS (AQ-Cardiology)

Senior Manager, Patient Care Services

Department of Pharmacy Services

Henry Ford Hospital

C.E. Credits: This activity is not eligible for continuing education credits.

Emerging Treatment Options for the Reversal of Oral Anticoagulant Therapy - Faculty Roundtable Discussion (Part 4 of 4)

Part 4: Reversal of Target-specific Oral Anticoagulants

Faculty:

Edith A. Nutescu, Pharm.D., FCCP, Chair and Moderator

Clinical Professor

The University of Illinois at Chicago College of Pharmacy

Director, Antithrombosis Center

The University of Illinois Hospital and Health Sciences System

Chicago, Illinois

William E. Dager, Pharm.D., BCPS (AQ-Cardiology)

Pharmacist Specialist

UC Davis Medical Center

Sacramento, California

James S. Kalus, Pharm.D., BCPS (AQ-Cardiology)

Senior Manager, Patient Care Services

Department of Pharmacy Services

Henry Ford Hospital

C.E. Credits: This activity is not eligible for continuing education credits.